Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
susceptibility panel | tested antimicrobial agents and organism-specific categories | The final susceptibility panel includes the agent under review. | Objective | Microbiology and specimen interpretation |
susceptibility testing | assessment of organism response to antimicrobial agents | Request review of final susceptibility testing before the planned antimicrobial reassessment. | Plan | Specimen collection, imaging and follow-up procedures |
symptom correlation | linking a reported symptom to a measurement or exposure over time | Review the diary for symptom correlation with the concentration changes. | Plan | Monitoring actions, escalation and result communication |
synchronous primary tumors | distinct primary tumors diagnosed in the same clinical period | Synchronous primary tumors were reviewed separately at the case conference. | Assessment | Cancer, treatment response and transplant assessment |
Takotsubo cardiomyopathy | Stress-associated syndrome with typically reversible ventricular dysfunction | The assessment includes Takotsubo cardiomyopathy after review of coronary imaging and ventricular recovery. | Assessment | Cardiopulmonary and vascular assessment |
taper | reduce gradually according to a plan | Taper according to the written schedule reviewed together. | Plan | Treatment decisions and medication changes |
target cells | red cells with centrally stained areas within pale zones | The manual review notes occasional target cells. | Objective | Hematology, coagulation and transfusion observations |
targeted | directed at an identified cause or target | Review options for targeted therapy once susceptibilities return. | Plan | Treatment decisions and medication changes |
target postdialysis weight | postdialysis weight selected by the dialysis team for the current clinical condition | Target postdialysis weight was reviewed after the change in edema and symptoms. | Assessment | Renal syndromes, dialysis and volume assessment |
temporary work restriction | time-limited limit on a defined task or activity at work | Specify the temporary work restriction and its review date in the letter. | Plan | Sampling, laboratory verification and communication |
threshold | defined point at which an action is taken | Record the agreed symptom threshold for earlier review. | Plan | Follow-up, contingency and functional care |
time-dependent interaction | interaction changes as time passes after starting or stopping an interacting agent | The time-dependent interaction was considered during review of the serial levels. | Assessment | Medication response, exposure and reconciliation |
time below range | percentage of sensor time below the stated glucose threshold | Time below range was reviewed separately for daytime and overnight periods. | Objective | Glucose monitoring, endocrine testing and urine studies |
timed urine instructions | directions for marking the start and end of a urine collection and managing missed voids | Review the timed urine instructions before the patient leaves. | Plan | Sampling, laboratory verification and communication |
timeframe | when a planned action should occur | Specify a timeframe for reviewing the pending result. | Plan | Follow-up, contingency and functional care |
tissue banking | preserving tissue for an agreed future use | Review the tissue consent before tissue banking. | Plan | Procedure, specimen and wound plans |
transition summary | concise account of active problems and pending actions at transfer | Send the transition summary with dates for the outstanding reviews. | Plan | Documentation, follow-up and transitions |
transporter-mediated interaction | one drug alters transport of another across cell membranes | The transporter-mediated interaction remains a potential explanation under pharmacology review. | Assessment | Medication response, exposure and reconciliation |
treatment failure | prespecified clinical or microbiological endpoint was not achieved | The team reviewed source control and exposure before concluding treatment failure. | Assessment | Infection, inflammation and evidence interpretation |
treatment trial endpoint | agreed criterion for judging a time-limited intervention | Set the treatment trial endpoint before starting and document who will review it. | Plan | Documentation, follow-up and transitions |
TSH receptor antibody | antibody binding the receptor for thyroid-stimulating hormone | The TSH receptor antibody was reviewed alongside the thyroid hormone measurements. | Objective | Glucose monitoring, endocrine testing and urine studies |
turnaround time | expected interval before a test or service is completed | Confirm the expected turnaround time before scheduling result review. | Plan | Specimen collection, imaging and follow-up procedures |
uncertain timing | relationship between the dose and the draw is unknown | Retain the numerical value and flag uncertain timing for clinician review. | Plan | Drug levels - verification and documentation |
unchanged regimen | dose and schedule remained the same over the stated interval | Confirm an unchanged regimen and review missed doses before classifying steady state. | Plan | Drug levels - verification and documentation |
underdosing | less than the intended dose was taken or supplied | The bottle review confirms underdosing relative to the current prescription. | Assessment | Risk, goals, medication assessment and function |